These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 26735018)
21. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas. Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148 [TBL] [Abstract][Full Text] [Related]
22. DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells. Chen B; McCuaig-Walton D; Tan S; Montgomery AP; Day BW; Kassiou M; Munoz L; Recasens A Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924599 [TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations. Rathmell WK; Hickey MM; Bezman NA; Chmielecki CA; Carraway NC; Simon MC Cancer Res; 2004 Dec; 64(23):8595-603. PubMed ID: 15574766 [TBL] [Abstract][Full Text] [Related]
24. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Groulx I; Lee S Mol Cell Biol; 2002 Aug; 22(15):5319-36. PubMed ID: 12101228 [TBL] [Abstract][Full Text] [Related]
25. The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions. Wang P; Yan Q; Liao B; Zhao L; Xiong S; Wang J; Zou D; Pan J; Wu L; Deng Y; Wu N; Gong S Cell Death Dis; 2020 Nov; 11(11):992. PubMed ID: 33208727 [TBL] [Abstract][Full Text] [Related]
26. Hydroxylation-Dependent Interaction of Substrates to the Von Hippel-Lindau Tumor Suppressor Protein (VHL). Heir P; Ohh M Methods Mol Biol; 2016; 1458():87-94. PubMed ID: 27581016 [TBL] [Abstract][Full Text] [Related]
27. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway. Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055 [TBL] [Abstract][Full Text] [Related]
28. HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5. Elorza A; Soro-Arnáiz I; Meléndez-Rodríguez F; Rodríguez-Vaello V; Marsboom G; de Cárcer G; Acosta-Iborra B; Albacete-Albacete L; Ordóñez A; Serrano-Oviedo L; Giménez-Bachs JM; Vara-Vega A; Salinas A; Sánchez-Prieto R; Martín del Río R; Sánchez-Madrid F; Malumbres M; Landázuri MO; Aragonés J Mol Cell; 2012 Dec; 48(5):681-91. PubMed ID: 23103253 [TBL] [Abstract][Full Text] [Related]
29. RHOBTB3 promotes proteasomal degradation of HIFα through facilitating hydroxylation and suppresses the Warburg effect. Zhang CS; Liu Q; Li M; Lin SY; Peng Y; Wu D; Li TY; Fu Q; Jia W; Wang X; Ma T; Zong Y; Cui J; Pu C; Lian G; Guo H; Ye Z; Lin SC Cell Res; 2015 Sep; 25(9):1025-42. PubMed ID: 26215701 [TBL] [Abstract][Full Text] [Related]
30. ASCL1 phosphorylation and ID2 upregulation are roadblocks to glioblastoma stem cell differentiation. Azzarelli R; McNally A; Dell'Amico C; Onorati M; Simons B; Philpott A Sci Rep; 2022 Feb; 12(1):2341. PubMed ID: 35149717 [TBL] [Abstract][Full Text] [Related]
31. Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL. Hasanov E; Chen G; Chowdhury P; Weldon J; Ding Z; Jonasch E; Sen S; Walker CL; Dere R Oncogene; 2017 Jun; 36(24):3450-3463. PubMed ID: 28114281 [TBL] [Abstract][Full Text] [Related]